GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » Market Cap

Prism Biolab Co (TSE:206A) Market Cap : 円8,317.3 Mil (As of Apr. 06, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Prism Biolab Co's share price for the quarter that ended in Sep. 2024 was 円410. Prism Biolab Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 36.0 Mil. Therefore, Prism Biolab Co's market cap for the quarter that ended in Sep. 2024 was 円14,741.6 Mil.

Prism Biolab Co's quarterly market cap stayed the same from Sep. 2023 (円0.0 Mil) to Mar. 2024 (円0.0 Mil) but then increased from Mar. 2024 (円0.0 Mil) to Sep. 2024 (円14,741.6 Mil).

Prism Biolab Co's annual market cap stayed the same from Sep. 2022 (円0.0 Mil) to Sep. 2023 (円0.0 Mil) but then increased from Sep. 2023 (円0.0 Mil) to Sep. 2024 (円14,741.6 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Prism Biolab Co's Enterprise Value for Today is 円3,925.2 Mil.


Prism Biolab Co Market Cap Historical Data

The historical data trend for Prism Biolab Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co Market Cap Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
Market Cap
- - 14,741.55

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24
Market Cap - - - 14,741.55

Competitive Comparison of Prism Biolab Co's Market Cap

For the Biotechnology subindustry, Prism Biolab Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prism Biolab Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prism Biolab Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Prism Biolab Co's Market Cap falls into.


;
;

Prism Biolab Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Prism Biolab Co's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as

Market Cap (A: Sep. 2024 )=Share Price (A: Sep. 2024 )*Shares Outstanding (EOP) (A: Sep. 2024 )
=円410*35.955
=円14,741.6

Prism Biolab Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=円410*35.955
=円14,741.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prism Biolab Co  (TSE:206A) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Prism Biolab Co Market Cap Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines